We are live on ! Find out more
OCRX

Ocera Therapeutics, Inc.
OCRX

Delisted

OCRX was delisted on the 8th of December, 2017.

Back to rankings

33 hedge funds and large institutions have $22.7M invested in Ocera Therapeutics, Inc. in 2016 Q1 according to their latest regulatory filings, with 6 funds opening new positions, 6 increasing their positions, 10 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

200% more first-time investments, than exits

New positions opened: 6 | Existing positions closed: 2

14% more funds holding

Funds holding: 29 → 33 (+4)

1% more capital invested

Capital invested by funds: $22.4M → $22.7M (+$320K)

40% less repeat investments, than reductions

Existing positions increased: 6 | Existing positions reduced: 10

Holders
33
Holders Change
+4
Holders Change %
+13.79%
% of All Funds
0.88%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.03%
New
6
Increased
6
Reduced
10
Closed
2
Calls
$114K
Puts
–
Net Calls
+$114K
Net Calls Change
+$64K

Top Buyers

Rank Fund Capital Flow
1
VMI
VHCP Management II
New York
+$2.71M
2
VM
VHCP Management
New York
+$265K
3
DM
Deerfield Management
New York
+$215K
4
BCM
Bridgeway Capital Management
Texas
+$151K
5
Renaissance Technologies
Renaissance Technologies
New York
+$118K

Top Sellers

Rank Fund Capital Flow
1
SFM
Sphera Funds Management
Israel
-$1.04M
2
TI
Turner Investments
Pennsylvania
-$638K
3
GTC
Ghost Tree Capital
New York
-$228K
4
Citadel Advisors
Citadel Advisors
Florida
-$59K
5
QSS
Quantitative Systematic Strategies
Florida
-$42K
Name Holding Trade Value Shares
Change 		Change in
Stake
GPP
1
Great Point Partners
Connecticut
$5.77M – – –
VMI
2
VHCP Management II
New York
$2.79M +$2.71M +948,372 New
QF
3
QVT Financial
New York
$2.45M – – –
VM
4
VHCP Management
New York
$2.34M +$265K +92,820 +13%
Millennium Management
5
Millennium Management
New York
$1.56M -$7.6K -2,663 -0.5%
TI
6
Turner Investments
Pennsylvania
$1.32M -$638K -223,487 -33%
Vanguard Group
7
Vanguard Group
Pennsylvania
$1.19M +$64.8K +22,710 +6%
SM
8
Sabby Management
Florida
$1.17M +$39.2K +13,735 +4%
WMSA
9
Weiss Multi-Strategy Advisers
New York
$579K – – –
SFM
10
Sphera Funds Management
Israel
$549K -$1.04M -363,200 -66%
VC
11
Vivo Capital
California
$451K +$437K +153,331 New
Renaissance Technologies
12
Renaissance Technologies
New York
$430K +$118K +41,300 +39%
ECM
13
Endurant Capital Management
California
$403K – – –
BCM
14
Bridgeway Capital Management
Texas
$399K +$151K +52,800 +64%
PVI
15
Pura Vida Investments
New York
$385K – – –
DM
16
Deerfield Management
New York
$221K +$215K +75,293 New
GTC
17
Ghost Tree Capital
New York
$132K -$228K -80,000 -64%
Bank of New York Mellon
18
Bank of New York Mellon
New York
$112K – – –
BFA
19
BlackRock Fund Advisors
California
$98K -$6.68K -2,343 -7%
Stifel Financial
20
Stifel Financial
Missouri
$96K -$927 -325 -1%
California Public Employees Retirement System
21
California Public Employees Retirement System
California
$90K – – –
Dimensional Fund Advisors
22
Dimensional Fund Advisors
Texas
$46K – – –
Northern Trust
23
Northern Trust
Illinois
$39K +$1.14K +400 +3%
VKH
24
Virtu KCG Holdings
New York
$39K +$38.2K +13,382 New
GT
25
Glenmede Trust
Pennsylvania
$33K – – –
1
2

OCRX Hedge Fund Activity: Q1 2016 in Review

33 of the 3,754 institutional investors tracked by Wall St. Rank reported a position in Ocera Therapeutics, Inc. (OCRX) for Q1 2016, worth a combined $22.7M — up 1.4% from $22.4M a quarter earlier.

Buyers outnumbered sellers: 6 funds opened new OCRX positions and 2 closed out — a net gain of 4 holders — while 6 added to existing stakes and 10 trimmed.

The largest buyer was VHCP Management II, opening a new position worth an estimated $2.71M. The largest seller was Sphera Funds Management, cutting an estimated $1.04M.

  • 33 institutional investors held Ocera Therapeutics, Inc. (OCRX) as of Q1 2016, up from 29 in Q4 2015.
  • Funds reported $22.7M of Ocera Therapeutics, Inc. stock for Q1 2016, up 1.4% quarter-over-quarter.
  • 6 funds opened new Ocera Therapeutics, Inc. positions in Q1 2016 and 2 closed out, a net change of +4 holders.
  • The largest Ocera Therapeutics, Inc. buyer in Q1 2016 was VHCP Management II, an estimated $2.71M added.
  • The largest Ocera Therapeutics, Inc. seller in Q1 2016 was Sphera Funds Management, an estimated $1.04M sold.

Based on aggregated 13F filings for Q1 2016.